Influence of age, sex and vitamin status on fasting and post-methionine load plasma homocysteine levels

Haematologica

Volumn 87, Issue 9, 2002, Pages 957-964

  Sassi, Simonetta ^a   Cosmi, Benilde ^a   Palareti, Gualtiero ^a   Legnani, Cristina ^a   Grossi, Gabriele ^a   Musolesi, Serena ^a   Coccheri, Sergio ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Cardiovascular disease; Folate; Homocysteine; Risk factor; Vitamin B12; Vitamin B6

Indexed keywords

CREATININE; CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; METHIONINE; PYRIDOXINE; VITAMIN;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; BLOOD LEVEL; COHORT ANALYSIS; CREATININE BLOOD LEVEL; DIET RESTRICTION; FEMALE; FOLIC ACID BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; REFERENCE VALUE; SEX; VITAMIN BLOOD LEVEL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AGING; FASTING; FEMALE; HOMOCYSTEINE; HUMANS; MALE; METHIONINE; MIDDLE AGED; SEX CHARACTERISTICS; TIME FACTORS; VITAMINS;

EID: 0036739683     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Am J Hum Genet 1991; 48:536-45.
2. Mudd SH, Levy HL, Skovb YF. Disorders in transsulfuration. In: The Metabolic and Molecular Basis of Metabolic Diseases. Scriver CR, Beaudet AL. Sly WS, Valle D, editors. New York, NY, McGraw Hill; 1995. p. 1279-327.
3. Ubbink JB, Vermaak WJ, van der Merwe A, Becker PJ. Vitamin B-12, vitamin B-6, and folate nutritional status in men with hyperhomocysteinemia. Am J Clin Nutr 1993; 57:47-53.
4. Pietrzik K, Bronstrup A. Causes and consequences of hyperhomocysteinemia. Int J Vit Nutr Res 1997; 67:389-95.
5. Palareti G, Salardi S, Piazzi S, Legnani C, Poggi M, Grauso F, et al. Blood coagulation changes in homocystinuria: the effects of pyridoxine and other specific therapy. J Pediatr 1986; 109:1001-6.
6. Refsum H, Ueland PM, Nygard O, Vollset SE. Homocysteine and cardiovascular disease. Annu Rev Med 1998; 49:31-62.
7. Legnani C, Palareti G, Grauso F, Sassi S, Grossi G, Piazzi S, et al. Hyperhomocyst(e)inemia and a common methylenetetrahydrofolate reductase mutation (Ala223Val, MTHFR) in patients with inherited thrombophilic coagulation defects. Atheroscler Thromb Vasc Biol 1997; 17:2924-9.
8. Palareti G, Legnani C, Coccheri S. Hyperhomocysteinemia and vascular disease. In: Hypercoagulable states. Fundamental aspects, acquired disorders, and congenital thrombophilia. Seghachian MJ, Samama MM, Hecker SP, editors. CRC Press, Inc: Boca Raton; 1996. p. 395-407.
9. Ueland PM, Refsum H, Beresford SAA, Vollset SE. The controversy over homocysteine and cardiovascular risk. Am J Clin Nutr 2000; 72:324-32.
10. Brattstrom L, Wilcken E. Homocysteine and cardiovascular disease: cause or effect? Am J Clin Nutr 2000; 72:315-23.
11. Lussier-Cacan S, Xhignesse M, Piolot A, Selhub J, Davignon J. Plasma total homocysteine in healthy subjects: sex-specific relation with biological traits. Am J Clin Nutr 1996; 64:587-93.
12. Andersson A, Brattstrom L, Israelsson B, Isaksson A, Hamfelt A, Hultberg B. Plasma homocysteine before and after methionine loading with regard to age, gender, and menopausal status. Eur J Clin Invest 1992; 22:79-87.
13. Russel RM. Changes in gastrointestinal function attributed to aging. Am J Clin Nutr 1992; Suppl 6 55:1203s-7s.
14. Wilcken DEL, Wilcken B. The pathogenesis of coronary artery disease, a possible role for methionine metabolism. J Clin Invest 1976; 57: 1079-82.
15. Sardharwalla IB, Fowler B, Robin AJ, Komrower GM. Detection of heterozygotes for homocystinuria. Arch Dis Child 1974; 49:553-9.
16. Brenton DP, Cusworth DC, Gaull GE. Homocystinuria: metabolic studies on 3 patients. J Pediatr 1965;67:58-68.
17. Silberberg J, Crooks R, Fryer J. Gender differences and other determinants of rise in plasma homocysteine after L-methionine loading. Atherosclerosis 1997;133:105-10.
18. Verhoef P, Meleady R, Daly LE, Graham IM, Robinson K, Boers GH. Homocysteine, vitamin status and risk of vascular disease; effects of gender and menopausal status. European COMAC Group. Eur Heart J 1999; 20:1234-44.
19. Araki A, Sako Y. Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detection. J Chromatogr 1987; 422: 43-52.
20. st International Symposium on high performance liquid phase separations and related techniques, Birmingham, UK, June 22-27, 1997.
21. Solberg HE. International Federation of Clinical Chemistry (IFCC), Scientific Committee, Clinical Section, Expert Panel on Theory of Reference Values, and International Committee for Standardization in Haematology (ICSH), Standing Committee on Reference Values. Approved Recommendation (1986) on the theory of reference values. Part 1. The concept of reference values. J Clin Chem Clin Biochem 1987; 25:337-42.
22. Brattstrom L, Lindgren A, Israelsson B, Andersson A, Hultberg B. Homocysteine and cysteine: determinants of plasma levels in middle-aged and elderly subjects. J Intern Med 1994; 236:633-41.
23. Robinson K, Arheart K, Refsum H, Brattstrom L, Boers G, Ueland P, et al. Low circulating folate and vitamin B6 concentrations: risk factors for stroke, peripheral vascular disease, and coronary artery disease. European COMAC Group. Circulation 1998; 97:437-43.
24. Malinow M. Homocyst(e)ine and arterial occlusive diseases. J Intern Med 1994; 236:603-17.
25. Fukagawa NK, Martin JM, Wurthmann A, Prue AH, Ebenstein D, O'Rourke B. Sex-related differences in methionine metabolism and plasma homocysteine concentrations. Am J Clin Nutr 2000; 72:22-9.
26. McKeer MP, Wier DG, Molloy A, Scott JM. Betaine-homocysteine methyltransferase: organ distribution in man, in pig and rat and subcellular distribution in the rat. Clin Sci (Lond) 1991; 81:551-6.
27. Guttormsen AB, Ueland PM, Svarstad E, Refsum H. Kinetic basis of hyperhomocysteinemia in patients with chronic renal failure. Kidney Int 1997; 52:495-502.
28. Mijatovic V, Kenemans P, Jakobs C, van Baal WM, PetersMuller ER, van der Mooren MJ. A randomized controlled study of the effects of 17β-estradiol-dydrogesterone on plasma homocysteine in postmenopausal women. Obstet Gynecol 1998; 91:432-6.
29. Mudd SH, Poole JR. Labile methyl balances for normal humans on various dietary regimens. Metabolism 1975; 24: 721-35.
30. Wouters MG, Moorrees MT, van der Mooren MJ, Blom HJ, Boers GH, Schellekens LA, et al. Plasma homocysteine and menopausal status. Eur J Clin Invest 1995; 25:801-5.
31. Wilcken D, Gupta VJ. Cysteine-homocysteine mixed disulphide: differing plasma concentrations in normal men and women. Clin Sci (Lond) 1979; 57:211-5.
32. Andersson A, Brattstrom L, Israelsson B, Isaksson A, Hamfelt A, Hultberg B. Plasma homocysteine before and after methionine loading with regard to age, gender, and menopausal status. Eur J Clin Invest 1992; 22:79-87.
33. Bostom AG, Jaques PF, Nadeau MR, Williams RR, Ellison RC, Selhub J. Post-methionine load hyperhomocystenemia in persons with normal fasting total plasma homocysteine: initial results from the NHLBI Family Heart Study. Atherosclerosis 1995; 116:147-51.
34. Selhub J, Miller JW. The pathogenesis of homocysteinemia: interruption of the coordinate regulation by S-adenosylmethionine of the remethylation and transsulfuration of homocysteine. Am J Clin Nutr 1992; 55:131-8.
35. Selhub J, Jacques PF, Wilson PW, Rush D, Rosenberg IH. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA 1993; 270:2693-8.
36. UbbinkJB, Becker PJ,Vermaak WJ, Delport R. Result of B-vitamin supplementation study used in a prediction model to define a reference range for plasma homocysteine. Clin Chem 1995; 41:1033-7.
37. Nygard O, Refsum H, Ueland PM, Vollset SE. Major lifestyle determinants of plasma total homocysteine distribution: the Hordaland Homocysteine Study. Am J Clin Nutr 1998; 67: 263-70.